Highridge Medical, a privately help spine company, has acquired the FlareHawk and Toro expandable interbody fusion systems, as well as the LineSider pedicle screw system, from Accelus.

The product transactions bolster Highridge’s position in the expandable interbody space by adding Accelus’ proprietary Adaptive Geometry implant designs to its portfolio. The company now has more advanced offerings for both the hospital and ambulatory surgery center (ASC) settings.

The FlareHawk expandable interbody fusion system touts a minimal insertion profile and controlled in-situ, multiplanar expansion, designed to restore foraminal height and sagittal balance while reducing subsidence and conforming to the patient’s endplates.

The Toro expandable interbody fusion system features multidirectional expandable cage technology and novel instrumentation. The company said the LineSider modular pedicle screw system is appreciated for its procedural visibility, versatility, and efficiency.

“As we build out a compelling Highridge product portfolio and deepen our commitment to innovative minimally invasive lumbar spine solutions, we believe these Accelus products are a great strategic fit for our business,” said Rebecca Whitney, CEO of Highridge Medical. “This agreement puts the differentiated products Accelus has developed into the hands of our established and comprehensive sales force to serve a broader market, allowing us to bring a more robust portfolio of spine solutions to our current and future surgeon customers and the patients they serve.”

The transaction is another milestone for the company, affirming its commitment to doubling its investment in R&D through both organic development and inorganic product and technology acquisitions.

“The sale of these products to Highridge Medical represents a win for our current surgeon customers and many others who will gain access as a result of Highridge’s broad sales and distribution network,” said Kevin McGann, president and CEO of Accelus. “We are proud of our clinical outcomes and are confident that Highridge Medical will further elevate and expand the impact of our product portfolio to benefit more surgeons and patients.”